Abdullah Beyoğlu
Kahramanmaraş, None Selected, 46040, Turkey (Türkiye)
NCT Number: NCT04776863
Observational, comparative, cross-sectional study
Looking for future studies?
Notify Me26 year–49 year
All sexes
Observational
Kahramanmaraş, None Selected, 46040, Turkey (Türkiye)
To evaluate the acute and chronic effects of smokeless tobacco (ST) on the anterior segment parameters using optical biometry. Observational, comparative, cross-sectional study Place and Duration of Study: Department of Ophthalmology, Kahramanmaras Sutcu Imam University.
The study included 53 right eyes of 53 subjects (study group), who used ST and 54 right eyes of 54 healthy subjects without ST (control group). Following a full ophthalmological examination, baseline measurements were taken with optical biometry and these measurements were repeated at 5, 30 and 60 mins after using ST.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The measurements of the individuals using smokeless tobacco and those who do not were taken by optical biometry.
Time frame: Baseline to 60 minutes after intervention
Change in Central Corneal Thickness (CCT
Time frame: Baseline to 60 minutes after intervention
Change in Axial Length (AL)
Time frame: Baseline to 60 minutes after intervention
Change in Anterior chamber deep (ACD)
Time frame: Baseline to 60 minutes after intervention
Change in Lens thickness (LT)
Time frame: Baseline to 60 minutes after intervention
Change in Pupillary diameter (PD)
Kahramanmaras Sutcu Imam University
Other
Evaluation of the Effect of Smokeless Tobacco on Anterior Segment Parameters
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06235346
Eye Diseases, Eye Manifestations
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT04831047
Blepharoptosis, Conjunctiva Inflamed
Miami, Florida, United States
View Trial DetailsNCT01588041
Eye Diseases, Eye Manifestations
Durham, North Carolina, United States
View Trial DetailsNCT04021225
Eye Diseases, Eye Manifestations
Aachen, North Rhine-Westphalia, Germany
View Trial Details